Aripiprazole Augmentation of Antidepressants in PTSD

Summary

The proposed investigation will determine the therapeutic potential of aripiprazole augmentation to a stable antidepressant regimen for reducing posttraumatic stress disorder (PTSD) symptoms, cognitive symptoms, psychotic symptoms, and depressive symptoms in veterans with PTSD.

Timeline

Start

2007-03

Primary completion

2008-09

Completion

2014-12

Drugs

Indications